Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
55%
Cardiovascular Disease
37%
Mouse
37%
Heart Ventricle Remodeling
24%
Prevalence
23%
Disease
22%
Heart Ventricle Hypertrophy
21%
Heart Failure
19%
Tumor Necrosis
18%
Isoprenaline
18%
Adverse Event
18%
Cardiovascular Risk
18%
P21 Activated Kinase 2
18%
Interleukin 10 Receptor
18%
Malignant Neoplasm
17%
Neoplasm
13%
Aortic Constriction
12%
Injury
12%
Interleukin 10
11%
Preclinical Study
9%
Cytokine
8%
Receptor
7%
Ischemic Heart Disease
6%
Heart Muscle Injury
6%
Fibrosis
5%
Biochemistry, Genetics and Molecular Biology
Cardiac Muscle Cell
100%
Mouse
34%
Hippo Signaling Pathway
20%
MicroRNA
18%
Interleukin-10 Receptor
18%
DNA Modification
18%
Stem Cell
18%
Induced Pluripotent Stem Cell
18%
Immune Response
15%
Heart Function
12%
Interleukin 10
11%
Human
9%
Stromal Cell
9%
Medline
9%
Growth Factor
9%
Cancer Cell
9%
Cytokine
9%
Cochrane Library
9%
Gene Induction
9%
Eicosanoid Receptor
7%
Cell Death
6%
Signal Transduction
6%
Physiological Process
6%
Protein Family
6%
Organogenesis
6%
Medicine and Dentistry
Cardiovascular Disease
37%
Prevalence
18%
Ventricular Hypertrophy
18%
Cardiovascular Risk
18%
Infusion
18%
Interleukin 10 Receptor
18%
Cardiovascular Disease Risk Factor
18%
P21 Activated Kinase 2
18%
Isoprenaline
18%
Endoplasmic reticulum
13%
Interleukin 10
11%
Cardiac Muscle Cell
8%
Blood Pressure
8%
Aortic Constriction
7%
Receptor
7%
Systolic Blood Pressure
6%
Drug Therapy
5%